Search
Main Menu
Main Content
Fermer
Choose language
FR
EN
Accessibility
Change contrast :
Standards
Reinforced
icone
HAS profile
Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest
International relations and projects
Publications
English content
Medicines
Opinions on medical devices
INAHTA briefs
French website
Chercher
Recherche
icone plus
English content
Les recommandations et guides
Les médicaments
Les actes professionnels
Les dispositifs médicaux
Les médecins accrédités
Les articles d'information
Les établissements de santé
Chercher
My account
My account
Email alert Subscription
Newsletter Subscription
My search
Refresh
Please fill in your email address to retrieve your email alerts subscriptions.
New subscription
Please fill in your email address to retrieve your newsletter subscriptions.
You do not have a saved search
Sélection
No element in selection
Contact
2 results
Topics : Blood and lymphatic diseases
Active substance : romiplostim
+
Chercher
Filter
Topic
Diseases and conditions
(2)
Plus ...
Blood and lymphatic diseases
(2)
Plus ...
Bone marrow diseases
(2)
Blood coagulation and hemostasis disorders
(1)
Congenital, genetic and rare diseases
(1)
Immune system diseases
(1)
Plus ...
Autoimmune diseases
(1)
Economics and public health
(1)
Plus ...
Health economics
(1)
Diagnostic and therapeutic techniques
(1)
Plus ...
Drug therapy
(1)
Content type
Drugs, devices and medical acts
(1)
Plus ...
Medicine
(1)
Practice Guidelines and Other Guides
(1)
Plus ...
Chronic disease guide
(1)
Date
Last five years
(1)
This year
(1)
Language
Français
(2)
Active substance
azacitidine
(1)
ciprofloxacine
(1)
eltrombopag
(1)
fer
(1)
romiplostim
(2)
Save your search
Practice guidelines and other guides
- 1 result
Bone marrow failures and other chronic cytopenias myelodysplastic syndromes
Chronic disease guide
- Posted on 20/11/2018
Download
guide
Add to
my selection
Drugs, devices and medical acts
- 1 result
NPLATE
Medicine
- Posted on 20/10/2021
Add to
my selection
Français
English
eNq1mG1v2jAQx9/3U6BI3TsI4Zktoep4WJFajRXYpr2JTHJAmLFT26GwTz8noQK60DKDX1Si9uXu7Pvn53Psm/US51bAeECJY1iFopED4lE/IDPHGI96+YZx07qyF2iF9s0ahaJrNSwj52HEuWPE84UJIMILPx/uOyA9ADNaVzmbThbgiQO7SAS4cIf4/AGFsU3OXtHAzy1BzKnvGGEkktGczQWTebSeKfvNQ+SBbW5H9mcXbmV/3DZjZyd4jTiwe0RmmU6BKPn0IsaAiDYSMKNsk+l66rmlRr3SLJWVQgT8ETiNmAcDJOYDRleBD352JIQ5KAWZPvtDYCsMIg6S6dxceEuu5Bwt0PoRnvrZSd/K2bZYi3wxb9Wq5Xq13ixXSpWiUii2t1XZ4pGLMNOKVK26ZQIx5TMRFkjkfcgz8ObA5J9iqQaUCYQ1FSng7UO5aYrD4OldMfgBDzHaFBY8VN0qxJCcBiahoG8h8QpGTGIKyz175Z9EGJv/mfV4CxFNGceMatOIiCMsGQ9VN6JNiYD18Yqq4U+st1oMgF/O7R9KstE/iCY48FQJJxkUARfjx/5xwGlkw2fEYcz0weFHQHz6zC8Pnf0ia8o+TLiZ6TRkvuWWmo2aVa0qv1O/pKKOnD/diNEQTImjgJ9DmT6Z0nP5IkWa7epForrUmfRG1EMYjnRHriJ5pCxfmjltwtf3UqUTmU6/dEeqavkWAdsMk38zXQe+s6uzGpd1wF6K873M46DOB7QMP4llmBzwjtiEwKfX5Y6QAiUU05mkyHWpNwMCLD6TC90VwhES8qLRAT7as+rAEMl1JP5oOAQk5Z16T3Hh7KMhGe/dtrsjd3TXfeg6nlur1KoVGSr5VT/VgkGIZXDHKu49MBx/dm/bo/73rsPoMggx5SJYXsjgoN5qI2dA94S7S7neaKphhWUzfS5EyD+a5hzxPI9rXJiyk4/fm53KdCjtX7W9pbjTNHW61Sv1naSfixipNgc70ui7mmrpXdNePm0MNKU+STu+018B1RPlvc723Nva9vntrTAb/SyCM+qQNh/aWoR+9/Jdx+6qpi3twQGh9YVJrlUJGHX199HkjfNF+QSThSU9JunwdToNjnwuPCpM20w/VbaubDP+TNm6+gsz+vJw
EpcpXCMpbW5hk1Ng